You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

P-gp

Showing 1 - 25 of 6,222
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Colorectal Cancer Trial in Austin (Fruquintinib, Dabigatran Etexilate, Rosuvastatin)

Completed
  • Metastatic Colorectal Cancer
  • Austin, Texas
    PPD Development
Oct 5, 2022

Immune System Disorder (Healthy Volunteers) Trial in Miami (Belumosudil, UGT1A1 victim drug, P-gp victim drug)

Completed
  • Immune System Disorder (Healthy Volunteers)
  • Miami, Florida
    Investigational Site Number: 8400001
Apr 11, 2023

Gender Trial ([18F]MC225)

Not yet recruiting
  • Gender
  • (no location specified)
Nov 8, 2022

NSCLC Trial in Jinan (DZD9008 and Probe drugs (midazolam, digoxin, rosuvastatin))

Recruiting
  • Non-small Cell Lung Cancer
  • DZD9008 and Probe drugs (midazolam, digoxin, rosuvastatin)
  • Jinan, Shandong, China
    Shandong Cancer Hospital (Shandong Provincial Institute of Cance
Jun 22, 2023

Relapsed or Refractory Lymphoma Trial in Austin (HMPL-523, Itraconazole, Rifampin)

Active, not recruiting
  • Relapsed or Refractory Lymphoma
  • Austin, Texas
    PPD Austin
Jan 31, 2023

Healthy Trial in Cypress, South Miami, San Antonio (Imlunestrant, Repaglinide, Omeprazole)

Completed
  • Healthy
  • Cypress, California
  • +2 more
Nov 23, 2022

Drug Drug Interaction Trial in Porto (Givinostat, Clarithromycin)

Completed
  • Drug Drug Interaction
  • Porto, Portugal
    Hospital da Prelada, 3rd Floor & East Wing 4th Floor Rua Sarment
Apr 26, 2023

Drug Interaction Trial in Uppsala (Drug Drug Interaction)

Recruiting
  • Drug Interaction
  • Drug Drug Interaction
  • Uppsala, Sweden
    CTC Clinical Trial Consultants AB
Apr 13, 2023

Healthy Male Subjects Trial (Savolitinib, Digoxin, Metformin Hydrochloride)

Not yet recruiting
  • Healthy Male Subjects
  • (no location specified)
Mar 3, 2023

DAPHNE Study: Direct Anticoagulant PHarmacogeNEtic

Completed
  • Anticoagulants and Bleeding Disorders
  • CYP3A4/5 and P-gp phenotyping
  • CYP3A4/5 and P-gp genotyping
  • Geneva, Switzerland
    HUG
Sep 29, 2021

Human Immunodeficiency Virus Type 1 (HIV-1) Infection Trial (Vesatolimod, Cobicistat, Voriconazole)

Not yet recruiting
  • Human Immunodeficiency Virus Type 1 (HIV-1) Infection
  • (no location specified)
Jul 11, 2022

Healthy Participants Trial in Brooklyn (AZD5462, Midazolam, Rosuvastatin)

Completed
  • Healthy Participants
  • Brooklyn, Maryland
    Research Site
Oct 10, 2022

Healthy Trial in Montréal (GLPG3667, Itraconazole)

Completed
  • Healthy
  • MontrĂ©al, Canada
    Altasciences
May 24, 2022

Drug-Drug Interaction Trial in Porto (ITF2357 Givinostat 10mg/mL, Midazolam 1Mg/Ml (Pf) Inj Syringe 5Ml, Midazolam Oral Liquid

Completed
  • Drug-Drug Interaction
  • ITF2357 Givinostat 10mg/mL
  • +4 more
  • Porto, Portugal
    Hospital da Prelada, 3rd Floor & East Wing 4th Floor Rua Sarment
Aug 4, 2022

Healthy Adults Trial in Dallas (Sitravatinib 50 mg, Sitravatinib 100 mg, Itraconazole)

Recruiting
  • Healthy Adults
  • Sitravatinib 50 mg
  • +3 more
  • Dallas, Texas
    Labcorp Drug Development Clinical Research Unit
Feb 23, 2022

Liver Cirrhosis Trial (Rosuvastatin, Digoxin, Metformin hydrochlorid)

Not yet recruiting
  • Liver Cirrhosis
  • (no location specified)
Feb 27, 2023

Ontogeny of P-glycoprotein Expression in Blood of Pediatric

Completed
  • Acute Lymphocytic Leukemia
  • MTX, (but the investigator is not using any intervention, the participants are already taking it in their treatment protocol and the investigator is just analyzing p-gp expression)
  • Tanta, Gharbiya, Egypt
  • +2 more
Aug 28, 2021

Healthy Volunteers Trial in Long Beach, Berlin (AZD9833, Midazolam, Omeprazole)

Recruiting
  • Healthy Volunteers
  • Long Beach, California
  • +1 more
Jul 26, 2022

P-gp, MRP2, ENT-1 and CNT3 on Blood Concentration / Intra-PBMC

Completed
  • Liver Transplantation
  • Kidney Transplantation
    • Rennes, France
      Rennes University Hospital
    Jan 12, 2021

    HIV Trial in United States (BG505 MD39.3 mRNA, BG505 MD39.3 gp151 mRNA, BG505 MD39.3 gp151 CD4KO mRNA)

    Suspended
    • HIV Infections
    • BG505 MD39.3 mRNA
    • +2 more
    • Birmingham, Alabama
    • +9 more
    Feb 1, 2023

    Pharmacokinetics, Safety Issues, Efficacy Trial in Russian Federation (GP30341 capsules 200 mg, Standard therapy)

    Completed
    • Pharmacokinetics
    • +2 more
    • GP30341 capsules 200 mg
    • Standard therapy
    • Kaliningrad, Russian Federation
    • +4 more
    Dec 7, 2022

    Healthy Subjects, Drug-drug Interaction, Pharmacokinetics Trial in San Antonio (Dabigatran Etexilate Mesylate, Quizartinib)

    Completed
    Has Results
    • Healthy Subjects
    • +3 more
    • San Antonio, Texas
      Worldwide Clinical Trials
    Jun 16, 2021

    Tumors Trial in Budapest (volasertib, itraconazole)

    Completed
    • Neoplasms
    • Budapest, Hungary
    • +1 more
    May 5, 2021

    HIV Trial in New York, Philadelphia (gp145 C.6980 Vaccine, Placebo, Aluminum Hydroxide Adjuvant)

    Completed
    Has Results
    • HIV Infections
    • gp145 C.6980 Vaccine
    • +2 more
    • New York, New York
    • +2 more
    Oct 6, 2021

    HIV Trial in United States (MPER-656 Liposome Vaccine, Placebo for MPER-656 Liposome Vaccine)

    Completed
    Has Results
    • HIV Infections
    • MPER-656 Liposome Vaccine
    • Placebo for MPER-656 Liposome Vaccine
    • Birmingham, Alabama
    • +5 more
    Jun 15, 2022